3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline (EBC-170074)
Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
641571-10-0
Purity
95%
Nilotinib is a kinase inhibitor used for the chronic phase treatment of Chronic Myeloid Leukemia (CML) that is Philadelphia chromosome positive and for the treatment of CML that is resistant to therapy containing imatinib.
Properties
Name
Nilotinib
Smiles
CC1=CN(C=N1)C=2C=C(NC(=O)C=3C=CC(C)=C(NC=4N=CC=C(N4)C=5C=CC=NC5)C3)C=C(C2)C(F)(F)F
Targets
Please log in to see this information
SDS
AMN-107 | Tasigna | [Bodipy-FL]-Nilotinib | nilotinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
AMN-107 | Tasigna | [Bodipy-FL]-Nilotinib | nilotinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.